Ceftriaxone and Fungaemia - a phase IV clinical study of FDA data

Summary:

Fungaemia is reported as a side effect among people who take Ceftriaxone (ceftriaxone sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Sepsis.

The phase IV clinical study analyzes which people have Fungaemia when taking Ceftriaxone. It is created by eHealthMe based on reports of 40,872 people who have side effects when taking Ceftriaxone from the FDA, and is updated regularly.

What is Ceftriaxone?

Ceftriaxone has active ingredients of ceftriaxone sodium. It is often used in typhoid fever. eHealthMe is studying from 40,991 Ceftriaxone users. Check the latest studies of Ceftriaxone.

What is Fungaemia?

Fungaemia (fungi circulate in the blood) is found to be associated with 271 drugs and 380 conditions by eHealthMe. Check the latest studies of Fungaemia.

On Jul, 10, 2026

40,872 people reported to have side effects when taking Ceftriaxone.
Among them, 44 people (0.11%) have Fungaemia.

Among these 44 people:

How long have people been on Ceftriaxone when they have Fungaemia? *

What is the gender of people who have Fungaemia when taking Ceftriaxone? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Fungaemia when taking Ceftriaxone? *

What are other drugs people take besides Ceftriaxone? *

Vancomycin: 19 people, 43.18%
Fluconazole: 10 people, 22.73%
Methylprednisolone: 6 people, 13.64%
Prednisone: 5 people, 11.36%
Furosemide: 4 people, 9.09%
Oxycontin: 4 people, 9.09%
Piperacillin And Tazobactam: 4 people, 9.09%
Prevacid: 4 people, 9.09%
Zoloft: 4 people, 9.09%
Ativan: 4 people, 9.09%

What are other side effects people have besides Fungaemia? *

Aspartate Aminotransferase Increased: 6 people, 13.64%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 6 people, 13.64%
Enterococcal Infection: 5 people, 11.36%
Endophthalmitis (inflammation of the internal coats of the eye): 5 people, 11.36%
Drug Ineffective: 4 people, 9.09%
Cardiac Arrest: 4 people, 9.09%
Acute Respiratory Failure: 4 people, 9.09%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 9.09%
Septic Shock (shock due to blood infection): 4 people, 9.09%
Fever: 4 people, 9.09%

What are the existing conditions these people have? *

Bacteraemia (presence of bacteria in the blood): 6 people, 13.64%
Sepsis (a severe blood infection that can lead to organ failure and death): 6 people, 13.64%
Fungal Oesophagitis (fungal inflammation of the oesophagus): 5 people, 11.36%
Inflammation: 4 people, 9.09%
Fever: 4 people, 9.09%
High Blood Pressure: 3 people, 6.82%
Staphylococcal Bacteraemia (a bacterial infection of blood): 3 people, 6.82%
Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 3 people, 6.82%
Hypotension (abnormally low blood pressure): 2 people, 4.55%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Ceftriaxone and have Fungaemia?

- Check whether Fungaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone:

Ceftriaxone (40,991 reports)

Fungaemia treatments and more:

Fungaemia (2,305 reports)

Browse all side effects of Ceftriaxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fungaemia:

Fungaemia (271 drugs)

Browse all the conditions that are associated with Fungaemia:

Fungaemia (380 conditions)

Related publications that referenced our studies

Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone) and Ceftriaxone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.